Cramer Peyton, Pua Bradley B
Division of Interventional Radiology, Department of Radiology, New York Presbyterian Hospital/Weill Cornell Medicine, New York, New York.
Semin Intervent Radiol. 2022 Aug 31;39(3):285-291. doi: 10.1055/s-0042-1753526. eCollection 2022 Jun.
Lung cancer is the second most common cancer in both men and women. Despite smoking cessation efforts and advances in lung cancer detection and treatment, long-term survival remains low. For early-stage primary lung carcinoma, surgical resection offers the best chance of long-term survival; however, only about one-third of patients are surgical candidates. For nonsurgical candidates, minimally invasive percutaneous thermal ablation therapies have become recognized as safe and effective treatment alternatives, including radiofrequency ablation, microwave ablation, and cryoablation. Lung ablation is also an acceptable treatment for limited oligometastatic and oligorecurrent diseases. This article discusses the technologies and techniques available for tumor ablation of thoracic malignancies, as well as new treatments on the horizon.
肺癌是男性和女性中第二常见的癌症。尽管在戒烟方面做出了努力，且肺癌检测和治疗也取得了进展，但长期生存率仍然很低。对于早期原发性肺癌，手术切除提供了最佳的长期生存机会；然而，只有约三分之一的患者适合手术。对于不适合手术的患者，微创经皮热消融治疗已被公认为安全有效的治疗选择，包括射频消融、微波消融和冷冻消融。肺消融也是局限性寡转移和寡复发性疾病的可接受治疗方法。本文讨论了用于胸部恶性肿瘤肿瘤消融的现有技术和技巧，以及即将出现的新治疗方法。
